Acceleron
Biotechnology ResearchUnited States51-200 Employees
Learn about working at Acceleron. Join LinkedIn today for free. See who you know at Acceleron, leverage your professional network, and get hired.
Investment Activity Acceleron has attracted significant attention from major pharmaceutical investors such as Merck and Avoro Capital, indicating strong market interest and potential collaboration or licensing opportunities.
Recent Acquisitions Merck’s substantial $11.5 billion buyout and ongoing negotiations highlight opportunities to offer specialized biotech solutions and technology partnerships aligned with their strategic growth.
Financial Range With annual revenues between 10 and 25 million dollars, Acceleron presents an accessible target for tailored financial and operational support services to help scale development and commercialization efforts.
Industry Focus As a biotech research firm specializing in TGF-beta therapeutics for rare diseases, there are opportunities to present advanced research tools, data management systems, and collaborative R&D partnerships.
Technology Stack Utilizing widespread solutions like MySQL, Google Analytics, and web security tools, Acceleron may benefit from enhanced data analytics, cybersecurity solutions, and digital transformation services tailored to biotech research.
Acceleron uses 8 technology products and services including MySQL, oEmbed, Font Awesome, and more. Explore Acceleron's tech stack below.
| Acceleron Email Formats | Percentage |
| FLast@acceleroninc.com | 45% |
| First.Last@acceleroninc.com | 5% |
| FLast@acceleroninc.com | 45% |
| First.Last@acceleroninc.com | 5% |
Biotechnology ResearchUnited States51-200 Employees
Learn about working at Acceleron. Join LinkedIn today for free. See who you know at Acceleron, leverage your professional network, and get hired.
Acceleron's revenue is estimated to be in the range of $10M$25M
Acceleron's revenue is estimated to be in the range of $10M$25M